Pentoxifylline attenuates leukoreduced stored blood-induced neutrophil activation through inhibition of mitogen-activated protein kinases

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 1, 2010, Pages 74-81

  Costantini, Todd W ^a   Deree, Jessica ^a   Martins, Joilson O ^a   Loomis, William H ^a   Bansal, Vishal ^a   Coimbra, Raul ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Mitogen activated protein kinase neutrophil; Oxidative burst; Pentoxifylline; Transfusion related immunomodulation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PENTOXIFYLLINE;

ARTICLE; BLOOD; ENZYME INHIBITION; ERYTHROCYTE PRESERVATION; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SUPERNATANT; VOLUNTEER;

ERYTHROCYTES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; NEUTROPHIL ACTIVATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; RESPIRATORY BURST;

BACTERIA (MICROORGANISMS);

EID: 77249112778     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903143965     Document Type: Article

References (56)

1. Chang H, Hall GA, Geerts WH, Greenwood C, McLeod RS, Sher G.D. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 2000;78 (1):13-18.
2. Chiarugi M, Buccianti P, Disarli M, Galatioto C, Cavina E. Effect of blood transfusions on disease-free interval after rectal cancer surgery. Hepatogastroenterology 2000;47 (34):1002-1005.
3. Croce MA, Tolley EA, Claridge JA, Fabian TC. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005;59 (1):19-23; discussion 23-114
4. Rovera F, Dionigi G, Boni L, Imperatori A, Tabacchi A, Carcano G, et al. Postoperative infections after oesophageal resections: the role of blood transfusions. World J Surg Oncol 2006;4:80.
5. Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma 2005;59 (3):717-723.
6. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002;30 (10):2249-2254.
7. Barrett NA, Kam PC. Transfusion-related acute lung injury: a literature review. Anaesthesia 2006;61 (8):777-785.
8. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287 (15):1968-1971.
9. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al., .Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33 (4):721-726.
10. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Silliman C.C. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction. J Trauma 2001;50 (3):426-431; discussion 432.
11. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002;137 (6):711-716; discussion 716-717.
12. Zallen G, Moore EE, Johnson JL, Tamura DY, Ciesla DJ, Silliman CC. Posthemorrhagic shock mesenteric lymph primes circulating neutrophils and provokes lung injury. J Surg Res. 1999;83 (2):83-88.
13. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001;41 (10):1244-1248.
14. Zimbelman J, Silliman CC, Ambruso DR. Transfusion-related acute lung injury and granulocytes from stored packed RBCs. Transfusion 2000;40 (5):614-615.
15. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol 2003;73 (4):511-524.
16. Varela M, Mas A, Nogues N, Escorsell A, Mazzara, R, Lozano M. TRALI associated with HLA class II antibodies. Transfusion 2002;42 (8):1102.
17. Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, et al.. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990;76 (7):1438-1444.
18. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006;34 (5 Suppl):S124-131.
19. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124 (5):684-694.
20. Silliman CC, Dickey WO, Paterson AJ, Thurman GW, Clay KL, Johnson CA, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996;36 (2):133-139.
21. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating- factor receptor. Vox Sang 1992;63 (2):133-136.
22. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101 (7):1458-1467.
23. Dewald B, Thelen M, Baggiolini M. Two transduction sequences are necessary for neutrophil activation by receptor agonists. J Biol Chem 1988;263 (31):16179-16184.
24. Dang PM, Morel F, Gougerot-Pocidalo MA, El Benna J. Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide- rich region. Biochemistry 2003;42 (15):4520-4526.
25. El Benna J, Han J, Park JW, Schmid E, Ulevitch RJ, Babior BM. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch Biochem Biophys 1996;334 (2):395-400.
26. Ward RA, Nakamura M, McLeish KR. Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinasedependent exocytosis of flavocytochrome b558-containing granules. J Biol Chem 2000;275 (47):36713-36719.
27. Coimbra R, Melbostad H, Hoyt DB. Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline. J Trauma 2004;56 (2):442-449.
28. Lauterbach R, Zembala M. pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996;155 (5):404-409.
29. Satapathy SK, Garg S, Chauhan R, Sakhuj P, Malhotra V, Sharma BC, et al.. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99 (10):1946-1952.
30. Deree J, Martins J, de Campos T, Putnam JG, Loomis WH, Wolf P, et al. pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock. J Surg Res 2007;143 (1):99-108.
31. Coimbra R, Melbostad H, Loomis W, Porcides, RD, Wolf, P, Tobar, M, et al. LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J Trauma 2006;60 (1):115-125.
32. Costantini TW, Loomis WH, Putnam JG, Drusinsky D, Deree J, Choi S, et al., Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock 2009;31 (4):416-422.
33. Costantini TW, Loomis WH, Putnam JG, Kroll L, Eliceiri BP, Baird A, et al. pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase. J Trauma 2009;66 (1):17-24; discussion 24-115
34. Lall RN, Loomis W, Melbostad H, Hoyt DB, Lane T, Coimbra, R. Phosphodiesterase inhibition attenuates stored blood-induced neutrophil activation: a novel adjunct to blood transfusion. J Am Coll Surg 2006;202 (1):10-17.
35. Coimbra R, Loomis W, Melbostad H, Tobar M, Porcides RD, Hoyt DB. LPS-stimulated PMN activation and proinflammatory mediator synthesis is downregulated by phosphodiesterase inhibition: role of pentoxifylline. J Trauma 2004;57 (6):1157-1163.
36. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5 (1):253-259.
37. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132 (6):620-624; discussion 624-625.
38. Chin-Yee I, Keeney M, Krueger L, Dietz G, Moses G. Supernatant from stored red cells activates neutrophils. Transfus Med 1998;8 (1):49-56.
39. Aiboshi J, Moore EE, Ciesla DJ, Silliman CC. Blood transfusion and the two-insult model of post-injury multiple organ failure. Shock 2001;15 (4):302-306.
40. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion 2005;45 (2 Suppl):109S-116S.
41. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, Kelher M, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol 2002;283 (6):C1592-1603.
42. Bahra PS, Rainger GE, Wautier JL, Nash GB. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils. Cell Biochem Funct 2001;19 (4):249-257.
43. Barroso-Aranda J, Schmid-Schonbein GW. pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 1990;27 (3-4):401-418.
44. Babior BM. NADPH oxidase. Curr Opin Immunol 2004, 16 (1), 42-47.
45. Dewas C, Fay M, Gougerot-Pocidalo MA, El-Benna J. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine- induced p47phox phosphorylation in human neutrophils. J Immunol 2000;165 (9):5238-5244.
46. El Benna J, Faust RP, Johnson JL, Babior BM. Phosphorylation of the respiratory burst oxidase subunit p47phox as determined by two-dimensional phosphopeptide mapping. Phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase. J Biol Chem 1996;271 (11):6374-6378.
47. Orlic T, Loomis W.H, Shreve A, Namiki S, Junger WG. Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and -independent mechanisms. Am J Physiol Cell Physiol 2002;282 (6):C1261-1269.
48. Bengis-Garber C, Gruener N. Protein kinase A downregulates the phosphorylation of p47 phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell Signal 1996;8 (4):291-296.
49. Ahmed MU, Hazeki K, Hazeki O, Katada T, Ui M. Cyclic AMPincreasing agents interfere with chemoattractant-induced respiratory burst in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase rather than receptor-operated Ca2+ influx. J Biol Chem 1995;270 (40):23816-23822.
50. Deree J, Melbostad H, Loomis WH, Putnam JG, Coimbra R. The effects of a novel resuscitation strategy combining pentoxifylline and hypertonic saline on neutrophil MAPK signaling. Surgery 2007;142 (2):276-283.
51. Jun T, Gjoerup O, Roberts TM. Tangled webs: evidence of crosstalk between c-Raf-1 and Akt. Scsi STKE 1999;1999 (13):PE1.
52. Nagaprasad V, Singh M. Sequential analysis of the influence of blood storage on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc 1998;18 (4):273-284.
53. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269 (23):3024-3029.
54. Bacher A, Eggensperger E, Koppensteiner R, Mayer N, Klimscha W. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion. Acta Anaesthesiol Scand 2005;49 (1):41-46.
55. Torres, M, Hall, FL, O'Neill, K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol 1993;150 (4):1563-1577.
56. Nick JA, Avdi NJ, Young SK, Knall C, Gerwin, P, Johnson GL, et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997;99 (5):975-986.